Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Bruen R, Curley S, Kajani S, Crean D, O'Reilly ME, Lucitt MB, Godson CG, McGillicuddy FC, Belton O
J Endocrinol Invest (2004) 27:93742.10.1007/BF03347536 46 Duran-PradoMGaheteMDMartinez-FuentesAJLuqueRMQuinteroAWebbSMet alIdentification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors
Once an ischemic stroke occurs, in spite of intense research efforts, little progress has been made in the discovery or development of effective neuroprotective agents
Vutiglabridin doses of 30 and 50 mg/kg/day were selected based on previous studies demonstrating dose-dependent anti-obesity effects in DIO mice [24, 25]
Published online May 16, 2024
US$ 20.15
US$ 26.85
US$ 20.48
US$ 22.14
US$ 20.23
US$ 20.85
US$ 20.73
